Login to Your Account



Exelixis, FDA Set SPA for XL184 Pivotal Study in Thyroid Cancer

By Tiffany Turner


Tuesday, June 17, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription